📈 Markets & Finance risk-off · 6–18 months
A what‑if from the future

What if Biotech-equity rout as funding dries and trials disappoint?

A frozen funding market and a cluster of clinical failures sink unprofitable biotech equities reliant on capital access. The drawdown punishes speculative names and trims sector risk appetite.

17%
our model probability
over 6–18 months
prediction markets — wisdom of the crowd
loading live odds…
Empirically anchored 17% · 90% range 0–35% · 40 analogues · measured class health 24% in 18 mo · 3% held back for the unknown
how we built this number — every step
Measured class rate — health ≈0.1843/yr → 24% in 18 mo24%
Analyst prior · editorial share 75% of the class18%
Pooled · weight 87%18%
Crowd — no liquid market
Reserve 3% · no extremizing (×1.0)18%
Published17%

The class rate is measured from our dated, sourced event library (decade-normalized Poisson — the full table is public at base_rates.json). The variant’s share within its class is the analyst’s editorial call, published so you can audit it. A wider range means thinner precedent. Full recipe: methodology · scored at Reality Check.

The butterfly cascade

How this trigger trickles across markets, left → right — the root shock, its first‑order moves, then the ripple effects. Drag any node; tap a market for its real price history.

Resolution timeline — how this probability is moving

Our model's odds (gold) over time vs the crowd's (Polymarket, blue), from the past toward the 6–18 months horizon. Each dot is a real macro event that nudged the probability — green pushed it up, red pushed it down. Tap a dot for the source. The gold path is an illustrative reconstruction anchored to today's estimate — real dated events, not a live re-estimate history.

loading the timeline…

What it would mean

If this plays out, it is a risk-off shock. A frozen funding market and a cluster of clinical failures sink unprofitable biotech equities reliant on capital access. The drawdown punishes speculative names and trims sector risk appetite. The trigger decomposes into signed root‑shocks — Volatility (VIX) ▲ · Biotech breakthrough ▼ · Credit spreads ▲ · Risk appetite ▼ — which propagate through our causal graph to the markets below.

If it happens — the markets it would move

Biggest moves first. Projected moves are cascade-model priors; hist A–B% = what comparable past events actually did (measured abnormal returns), and model prior · unmeasured marks markets with no analogue backing yet. Tap any market for its price history.

MarketClassProjected move
1MicroStrategy MSTRon Hyperliquid 📈 chartEquity▼ -0.8%
hist -2.77–+4.32%
2Solana SOLon Hyperliquid 📈 chartCrypto▼ -0.7%
hist -12.55–+1.24%
3Volatility (VIX) VIXon Hyperliquid 📈 chartVol▲ +0.7%
hist -0.25–+1.43%
4Hyperliquid (HYPE) HYPEon HyperliquidCrypto▼ -0.6%
model prior · unmeasured
5Nasdaq 100 NDXon Hyperliquid 📈 chartIndex▼ -0.5%
hist -0.42–+0.22%
6Ether ETHon Hyperliquid 📈 chartCrypto▼ -0.5%
hist -5.22–+1.57%
7Bitcoin BTCon Hyperliquid 📈 chartCrypto▼ -0.5%
hist -1.66–+3.59%
8S&P 500 SPXon Hyperliquid 📈 chartIndex▼ -0.4%
hist -0.21–-0.12%
9High-yield credit HYG 📈 chartRate▼ -0.4%
hist -0.25–-0.12%
10Tech sector XLK 📈 chartEquity▼ -0.4%
hist -0.43–+0.43%
11Financials XLF 📈 chartEquity▼ -0.3%
hist -0.96–+0.2%
12Coinbase COINon Hyperliquid 📈 chartEquity▼ -0.3%
hist -0.99–+0.99%
13JPMorgan JPM 📈 chartEquity▼ -0.2%
hist -0.82–+0.22%
14Semiconductors SMHon Hyperliquid 📈 chartEquity▼ -0.2%
hist -0.53–+1.2%

Probable recommendation

If the scenario above plays out, the probable cross‑asset positioning → a scenario‑conditional read, not personalized investment advice
Cash / hedgeRaise cash and hold the long hedges above; this scenario is net risk-off.
For a common-man portfolio: A typical stock-heavy portfolio is at risk. Consider trimming equities, raising cash, and a small cash hedge.
Also moves (not yet on Hyperliquid): High-yield credit -0.4% · Tech sector -0.4% · Financials -0.3% · JPMorgan -0.2%

Historical precedent — what analogous events actually did

Across 40 analogous events (overlap‑weighted), as abnormal returns — market beta stripped, so it's the event's own effect, not the market backdrop. Shown at 20 days (persistent) and 5 days (immediate); ↺ fades = the two horizons disagree. Confidence = consistency × sample × significance.

Wegovy 2021-06 First mRNA COVID-19 vaccine authorized 2020-12 Casgevy — first CRISPR gene-editing medicine approved 2023-12 mRNA pioneers win the Nobel 2023-10 First genetically-modified pig-to-human heart transplant 2022-01 AlphaFold cracks the protein-folding problem 2020-11 He Jiankui announces CRISPR-edited babies 2018-11 Human Genome Project completed 2003-04 Israel strikes Iran — Operation Rising Lion 2025-06 Nikkei 225 record single-day rebound 2024-08 VIX third-highest spike on record 2024-08 Neuralink implants its first human brain-computer interface 2024-01 LK-99 room-temperature superconductor claim 2023-07 First Republic Bank seized and sold to JPMorgan 2023-05 OpenAI releases GPT-4 2023-03 Regional-bank panic deepens after Signature seizure 2023-03 NIF achieves fusion ignition 2022-12 Kaisa Group offshore default 2021-12 Evergrande debt crisis - global selloff 2021-09 COVID-19 fourth circuit breaker 2020-03 COVID-19 second Level-1 circuit breaker 2020-03 Worst Christmas Eve selloff on record 2018-12 February 2018 hot wage print triggers rate scare 2018-02 North Korea 'fire and fury' nuclear scare 2017-08 AlphaGo defeats Lee Sedol 2016-03 SpaceX lands an orbital rocket booster 2015-12 China-led global 'Black Monday' rout 2015-08 HYG record outflows in 2014 high-yield rout 2014-10 Mt. Gox collapse 2014-02 Mt. Gox halts withdrawals 2014-02 Cyprus deposit bail-in 2013-03 Spain requests EUR100bn bank bailout 2012-06 SEC approves Limit Up-Limit Down plan and revised market-wide circuit breakers 2012-05 Bankia nationalised in Spain's banking crisis 2012-05 US-downgrade Black Monday equity rout and VIX spike to 48 2011-08 Portugal requests EU-IMF bailout 2011-04 Egyptian revolution / Mubarak uprising 2011-01 EU/IMF EUR750bn rescue weekend 2010-05 Greece first EU/IMF bailout 2010-05 Greece requests EU/IMF bailout 2010-04
AssetHistory saysAbnormal (20d · 5d)HitnConfidencevs cascade
SOL SOLSHORT-9.9% · 5d -9.4%86%17 0.52✓ matches cascade
AVGO AVGOLONG+3.4% · 5d -0.8% ↺ fades67%39 0.30⚠ differs
Gold XAULONG+1.1% · 5d +0.2%61%40 0.19·
ETH ETHSHORT-4.6% · 5d -6.8%60%22 0.17✓ matches cascade
SPX SPXLONG+0.0% · 5d +0.0%59%40 0.17⚠ differs
XLF XLFSHORT-0.8% · 5d -1.2%60%40 0.17✓ matches cascade
SMH SMHLONG+1.2% · 5d +0.5%60%40 0.16⚠ differs
Bitcoin BTCLONG+3.6% · 5d -4.3% ↺ fades57%27 0.13⚠ differs
High-yield credit HYGSHORT-0.0% · 5d -0.2%57%39 0.11✓ matches cascade
NDX NDXLONG+0.4% · 5d -0.3% ↺ fades56%40 0.08⚠ differs
JPM JPMSHORT-0.7% · 5d -1.5%54%40 0.07✓ matches cascade
XLK XLKLONG+0.6% · 5d +0.0%52%40 0.04⚠ differs
AMD AMDLONG+0.8% · 5d +0.6%52%40 0.03⚠ differs
TSM TSMLONG+0.5% · 5d -0.7% ↺ fades51%40 0.02⚠ differs

Methodology. Probability and impact are anchored to history and scored against what actually happens — wins and losses, in public, at Reality Check. Crowd odds live from Polymarket & Kalshi. By Vikas Singh, Quantitative Strategist. Updated 2026-07-03.